SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 21 filers reported holding SAVARA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,232,565 | +18.3% | 10,908,086 | 0.0% | 0.21% | +14.4% |
| Q2 2023 | $34,851,335 | +63.8% | 10,908,086 | 0.0% | 0.18% | +53.4% |
| Q1 2023 | $21,270,768 | +35.4% | 10,908,086 | +7.6% | 0.12% | +25.5% |
| Q4 2022 | $15,709,190 | +2.3% | 10,134,961 | +2.3% | 0.09% | +10.6% |
| Q3 2022 | $15,358,000 | +5.5% | 9,908,086 | +3.5% | 0.08% | +7.6% |
| Q2 2022 | $14,557,000 | +30.6% | 9,577,273 | +12.6% | 0.08% | +46.3% |
| Q1 2022 | $11,142,000 | +15.6% | 8,505,403 | +9.5% | 0.05% | +12.5% |
| Q4 2021 | $9,635,000 | +7.2% | 7,770,262 | +19.3% | 0.05% | +14.3% |
| Q3 2021 | $8,987,000 | -3.0% | 6,512,086 | +19.4% | 0.04% | +10.5% |
| Q2 2021 | $9,269,000 | +8.0% | 5,452,086 | +32.1% | 0.04% | -11.6% |
| Q1 2021 | $8,582,000 | +67.6% | 4,125,877 | -7.3% | 0.04% | +38.7% |
| Q4 2020 | $5,120,000 | +5.5% | 4,452,086 | 0.0% | 0.03% | -8.8% |
| Q3 2020 | $4,853,000 | -56.4% | 4,452,086 | -0.4% | 0.03% | -61.8% |
| Q2 2020 | $11,133,000 | +8.8% | 4,470,964 | -7.3% | 0.09% | +1.1% |
| Q1 2020 | $10,229,000 | -52.7% | 4,825,086 | 0.0% | 0.09% | -39.7% |
| Q4 2019 | $21,616,000 | +132.3% | 4,825,086 | +37.4% | 0.15% | +108.6% |
| Q3 2019 | $9,304,000 | +13.0% | 3,510,787 | +1.0% | 0.07% | +29.6% |
| Q2 2019 | $8,236,000 | -53.9% | 3,475,000 | +43.3% | 0.05% | -59.7% |
| Q1 2019 | $17,872,000 | -2.6% | 2,425,000 | 0.0% | 0.13% | -0.7% |
| Q4 2018 | $18,357,000 | -32.0% | 2,425,000 | +0.3% | 0.14% | -15.1% |
| Q3 2018 | $26,985,000 | +7.1% | 2,418,009 | +8.7% | 0.16% | +1.9% |
| Q2 2018 | $25,187,000 | +23.0% | 2,225,000 | 0.0% | 0.16% | +9.9% |
| Q1 2018 | $20,470,000 | -38.0% | 2,225,000 | 0.0% | 0.14% | -47.0% |
| Q4 2017 | $33,019,000 | +58.7% | 2,225,000 | 0.0% | 0.27% | +44.9% |
| Q3 2017 | $20,804,000 | +59.0% | 2,225,000 | 0.0% | 0.18% | +36.0% |
| Q2 2017 | $13,083,000 | – | 2,225,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,128,593 | $5,898,000 | 0.37% |
| FARALLON CAPITAL MANAGEMENT LLC | 4,452,086 | $5,120,000 | 0.03% |
| Woodline Partners LP | 374,904 | $431,000 | 0.01% |
| Gyon Technologies Capital Management, LP | 19,679 | $23,000 | 0.01% |
| AXA S.A. | 1,895,554 | $2,180,000 | 0.01% |
| WEXFORD CAPITAL LP | 31,253 | $36,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 192,100 | $221,000 | 0.01% |
| Capital Advantage, Inc. | 14,658 | $18,000 | 0.01% |
| RGT Wealth Advisors, LLC | 10,000 | $12,000 | 0.00% |
| Crewe Advisors LLC | 3,910 | $4,000 | 0.00% |